Connecticut 2023 Regular Session

Connecticut House Bill HB05452

Introduced
1/17/23  
Introduced
1/17/23  
Refer
1/17/23  

Caption

An Act Prohibiting Health Insurance Companies From Requiring Prior Authorization And Step Therapy.

Impact

The potential impact of HB 05452 is significant, especially for patients who often face delays in receiving medications that their doctors deem necessary. If passed, it could streamline the process for changing prescriptions by eliminating the necessity for health insurance companies to approve changes that healthcare providers advocate. The intention behind this legislation is to ensure that patients receive the medications that suit their needs without unnecessary obstacles or delays.

Summary

House Bill 05452 aims to exempt patients from the cumbersome requirements of prior authorization and step therapy imposed by health insurance companies. The legislation seeks to amend Title 38a of the general statutes, thereby prohibiting insurers from requiring prior authorization for treatment or the prescription of a drug to be refilled more than once before a patient’s healthcare provider can prescribe a different medication. This bill is positioned as a means to enhance patient care by ensuring timely access to necessary treatments without bureaucratic delays.

Conclusion

Ultimately, HB 05452 reflects a push towards improving patient autonomy in healthcare decisions while balancing the need for efficient cost management within the insurance system. The ongoing dialogue surrounding this bill will likely center on its long-term implications for healthcare affordability, prescription practices, and patient health outcomes.

Contention

Despite its patient-centric focus, the bill may face opposition from stakeholders within the healthcare and insurance sectors. Proponents argue that the bill will remove barriers to care and foster better patient outcomes. However, some critics might contend that eliminating prior authorization will lead to increased prescription costs and a lack of consideration for the appropriateness of certain treatments, effectively circumventing mechanisms that ensure both cost-effectiveness and medical necessity.

Companion Bills

No companion bills found.

Previously Filed As

CT SB00182

An Act Prohibiting Certain Health Carriers From Requiring Step Therapy For Prescription Drugs Used To Treat A Mental Or Behavioral Health Condition Or A Chronic, Disabling Or Life-threatening Condition.

CT HB05503

An Act Concerning Insurance Market Conduct And Insurance Licensing, The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes And Captive Insurance.

CT SB00372

An Act Concerning A Working Group To Study Payments By Insurance Companies For Deposit Into The Insurance Fund.

CT SB00400

An Act Concerning The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes.

CT SB00398

An Act Concerning The Regulation And Taxation Of Travel Insurance And Associated Entities, Products And Professionals.

CT SB00008

An Act Concerning Drug Affordability.

CT HB05054

An Act Addressing Health Care Affordability.

CT HB05470

An Act Concerning Transportation Network Companies And Third-party Delivery Companies.

CT HB05377

An Act Concerning The Connecticut Health Insurance Exchange.

CT SB00210

An Act Concerning A State-operated Reinsurance Program, Health Care Cost Growth And Site Of Service Billing Requirements.

Similar Bills

No similar bills found.